BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 26946441)

  • 1. Modelling the PKPD of oxycodone in experimental pain - Impact of opioid receptor polymorphisms.
    Olsen R; Foster DJ; Upton RN; Olesen AE; Ross JR; Droney J; Sato H; Drewes AM; Kreilgaard M
    Eur J Pharm Sci; 2016 Apr; 86():41-9. PubMed ID: 26946441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The genetic influences on oxycodone response characteristics in human experimental pain.
    Olesen AE; Sato H; Nielsen LM; Staahl C; Droney J; Gretton S; Branford R; Drewes AM; Arendt-Nielsen L; Riley J; Ross J
    Fundam Clin Pharmacol; 2015 Aug; 29(4):417-25. PubMed ID: 26042474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic-pharmacodynamic modeling of morphine and oxycodone concentrations and analgesic effect in a multimodal experimental pain model.
    Staahl C; Upton R; Foster DJ; Christrup LL; Kristensen K; Hansen SH; Arendt-Nielsen L; Drewes AM
    J Clin Pharmacol; 2008 May; 48(5):619-31. PubMed ID: 18440921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The antinociceptive effect and adverse drug reactions of oxycodone in human experimental pain in relation to genetic variations in the OPRM1 and ABCB1 genes.
    Zwisler ST; Enggaard TP; Noehr-Jensen L; Mikkelsen S; Verstuyft C; Becquemont L; Sindrup SH; Brosen K
    Fundam Clin Pharmacol; 2010 Aug; 24(4):517-24. PubMed ID: 19845769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analgesic efficacy of peripheral kappa-opioid receptor agonist CR665 compared to oxycodone in a multi-modal, multi-tissue experimental human pain model: selective effect on visceral pain.
    Arendt-Nielsen L; Olesen AE; Staahl C; Menzaghi F; Kell S; Wong GY; Drewes AM
    Anesthesiology; 2009 Sep; 111(3):616-24. PubMed ID: 19672186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic polymorphisms and drug interactions modulating CYP2D6 and CYP3A activities have a major effect on oxycodone analgesic efficacy and safety.
    Samer CF; Daali Y; Wagner M; Hopfgartner G; Eap CB; Rebsamen MC; Rossier MF; Hochstrasser D; Dayer P; Desmeules JA
    Br J Pharmacol; 2010 Jun; 160(4):919-30. PubMed ID: 20590588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Different effects of morphine and oxycodone in experimentally evoked hyperalgesia: a human translational study.
    Olesen AE; Staahl C; Arendt-Nielsen L; Drewes AM
    Br J Clin Pharmacol; 2010 Aug; 70(2):189-200. PubMed ID: 20653672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxycodone alters temporal summation but not conditioned pain modulation: preclinical findings and possible relations to mechanisms of opioid analgesia.
    Suzan E; Midbari A; Treister R; Haddad M; Pud D; Eisenberg E
    Pain; 2013 Aug; 154(8):1413-8. PubMed ID: 23707271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The hypoalgesic effect of oxycodone in human experimental pain models in relation to the CYP2D6 oxidation polymorphism.
    Zwisler ST; Enggaard TP; Noehr-Jensen L; Pedersen RS; Mikkelsen S; Nielsen F; Brosen K; Sindrup SH
    Basic Clin Pharmacol Toxicol; 2009 Apr; 104(4):335-44. PubMed ID: 19281600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A pharmacokinetic and pharmacodynamic study of oral oxycodone in a human experimental pain model of hyperalgesia.
    Olesen AE; Upton R; Foster DJ; Staahl C; Christrup LL; Arendt-Nielsen L; Drewes AM
    Clin Pharmacokinet; 2010 Dec; 49(12):817-27. PubMed ID: 20873879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Dose-Finding Study of Dexketoprofen in Patients Undergoing Laparoscopic Cholecystectomy: A Randomized Clinical Trial on Effects on the Analgesic Concentration of Oxycodone.
    Piirainen A; Kokki H; Immonen S; Eskelinen M; Häkkinen MR; Hautajärvi H; Kokki M
    Drugs R D; 2015 Dec; 15(4):319-28. PubMed ID: 26364041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of association of OPRM1 and ABCB1 single-nucleotide polymorphisms to oxycodone response in postoperative pain.
    Zwisler ST; Enggaard TP; Mikkelsen S; Verstuyft C; Becquemont L; Sindrup SH; Brosen K
    J Clin Pharmacol; 2012 Feb; 52(2):234-42. PubMed ID: 21383334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence from genetic variability on opioid use for cancer pain: a European genetic association study of 2294 cancer pain patients.
    Klepstad P; Fladvad T; Skorpen F; Bjordal K; Caraceni A; Dale O; Davies A; Kloke M; Lundström S; Maltoni M; Radbruch L; Sabatowski R; Sigurdardottir V; Strasser F; Fayers PM; Kaasa S;
    Pain; 2011 May; 152(5):1139-1145. PubMed ID: 21398039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gender, variation in opioid receptor genes and sensitivity to experimental pain.
    Sato H; Droney J; Ross J; Olesen AE; Staahl C; Andresen T; Branford R; Riley J; Arendt-Nielsen L; Drewes AM
    Mol Pain; 2013 Apr; 9():20. PubMed ID: 23570317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics and pharmacodynamics of oral oxycodone in healthy human subjects: role of circulating active metabolites.
    Lalovic B; Kharasch E; Hoffer C; Risler L; Liu-Chen LY; Shen DD
    Clin Pharmacol Ther; 2006 May; 79(5):461-79. PubMed ID: 16678548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Population pharmacokinetic-pharmacodynamic modelling of liquid and controlled-release formulations of oxycodone in healthy volunteers.
    Ladebo L; Foster DJR; Abuhelwa AY; Upton RN; Kongstad KT; Drewes AM; Christrup LL; Olesen AE
    Basic Clin Pharmacol Toxicol; 2020 Mar; 126(3):263-276. PubMed ID: 31597014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Development of opioid tolerance -- molecular mechanisms and clinical consequences].
    Freye E; Latasch L
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2003 Jan; 38(1):14-26. PubMed ID: 12522725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparative study of oxycodone and morphine in a multi-modal, tissue-differentiated experimental pain model.
    Staahl C; Christrup LL; Andersen SD; Arendt-Nielsen L; Drewes AM
    Pain; 2006 Jul; 123(1-2):28-36. PubMed ID: 16600508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Population pharmacokinetics of oxycodone in patients with cancer-related pain.
    Komatsu T; Kokubun H; Suzuki A; Takayanagi R; Yamada Y; Matoba M; Yago K
    J Pain Palliat Care Pharmacother; 2012 Sep; 26(3):220-5. PubMed ID: 22973910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetic properties of combination oxycodone plus racemic ibuprofen: two randomized, open-label, crossover studies in healthy adult volunteers.
    Kapil R; Nolting A; Roy P; Fiske W; Benedek I; Abramowitz W
    Clin Ther; 2004 Dec; 26(12):2015-25. PubMed ID: 15823765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.